Monday, 28 September 2026Updated 15m ago

Market pulse › USFDA

USFDA

Organisation tag · tracked since 24 Sept · also us fda, fda, us food and drug administration

Filter Top stories

Today2 stories · 2 articles8 stories since 24 Sept

Net tone▲ +100% today+44% over the week

Market checkLupin −0.4%Companies most often in its stories · Fri, 25 Sept

Developing0 storylinesNone active in the last 14 days

Stories per day

Bar colour is the day’s tone · tracking began on 24 Sept

224 Sept

025 Sept

426 Sept

027 Sept

228 Sept

Often tagged with

stories together this week · colour is their tone

Pharma and healthcare7 Farm commodities1 Lupin1 Morepen Laboratories1 Sugar and ethanol1 Zydus Lifesciences1

Stories

8 in all · newest first

Order win▲ bullishLupin receives USFDA tentative approval for Apixaban Oral Suspension 1.25 mg/mLLupin received USFDA tentative approval for Apixaban Oral Suspension 1.25 mg/mLLupin Pharma and healthcare1 source
35m

▲ bullishMorepen Laboratories submits first ANDA to USFDA for Sitagliptin TabletsMorepen Laboratories submitted its first ANDA to USFDA for Sitagliptin TabletsMorepen Laboratories Pharma and healthcare1 source
1h

● mixedFDA recalls 1.7 million pounds of sugar: Check if your brown or powdered sugar is affectedFDA classified the recall of nearly 1.7 million pounds of brown and powdered sugar as Class IISugar and ethanol Farm commodities1 source
2d

▲ bullishZydus Lifesciences’ New Jersey office clears USFDA inspection with no observationsUSFDA inspection concluded with nil observationsZydus Lifesciences Pharma and healthcare2 sources
1d

● mixedUS FDA approves AbbVie's drug for Parkinson's diseasePharma and healthcare1 source
2d

Policy● mixedUS FDA approves Mirum's drug for rare bone disorderPharma and healthcare1 source
2d

● mixedFDA upgrades Vitruvias Therapeutics recall: Superpotent thyroid tablets could trigger heart problems; who is at risk?FDA classified Vitruvias Therapeutics’ thyroid-tablet recall as Class I over potential superpotencyPharma and healthcare1 source
4d

● mixedFDA Nominee to Face Senators Frustrated by US Vaccine PoliciesPharma and healthcare1 source
4d